| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 09/05/2007 | CN101031292A Composition inhibiting sex hormone-binding globulin |
| 09/05/2007 | CN101029080A Methods and compositions for derepression of IAP-inhibited caspase |
| 09/05/2007 | CN101029051A (pyrido/thieno)-(f)-oxazepin-5-one derivatives as positive modulators of the ampa receptor |
| 09/05/2007 | CN101029046A Substituted isoandrographolide derivative, its production and medicinal composition |
| 09/05/2007 | CN101029042A Bicyclic androgen and progesterone receptor modulator compounds and methods |
| 09/05/2007 | CN101028408A Chinese medicinal composition for treating red sweat |
| 09/05/2007 | CN101028268A Pharmaceutical compositions |
| 09/05/2007 | CN101028259A Water soluble paclitaxel product |
| 09/05/2007 | CN101028138A Health-care cigarette |
| 09/05/2007 | CN101028098A Food composition containing |
| 09/05/2007 | CN100335900C Novel self-assembly molecules |
| 09/05/2007 | CN100335479C Bicyclic inhibitors of glycogen synthase kinase 3 |
| 09/05/2007 | CN100335478C Chemokine receptor binding heterocyclic compounds |
| 09/05/2007 | CN100335136C Pharmaceutical composition having reduced tendency for drug crystallization |
| 09/05/2007 | CN100335132C Combination therapy using receptor tyrosine kinase inhibitors and angiogenesis inhibitors |
| 09/05/2007 | CN100335124C IL-2 precursor liposome and its preparation method |
| 09/05/2007 | CN100335117C Chinese medicinal lotion for new-borne baby's removing jaundice |
| 09/05/2007 | CN100335106C Traditional Chinese medicine composition for treating intelligence impairment and dementia and preparation method thereof |
| 09/05/2007 | CN100335062C Use of Ginkgo biloba flavonoidic extract substantially devoid or terpenes for oral hygiene and composition contg. same |
| 09/05/2007 | CN100335060C Combination of cytochome p450 dependent protease inhibitors |
| 09/05/2007 | CN100335045C Ascites preventives for poultry |
| 09/04/2007 | USRE39821 Manufacture and expression of large structural genes |
| 09/04/2007 | US7266483 System and methods for optimized drug delivery and progression of diseased and normal cells |
| 09/04/2007 | US7265260 Transgenic non-human mammals expressing constitutively activated tyrosine kinase receptors |
| 09/04/2007 | US7265229 Method for synthesizing macrosphelides |
| 09/04/2007 | US7265228 N-(alpha-methylolbenzyl)1-(aminoethyl)- or 1-(aminocarbonyl)-2-aryl(especially phenyl or benzodioxanyl)-2-hydroxyethylamine intermediates for enantiomeric synthesis of amino ceramide-like compounds |
| 09/04/2007 | US7265227 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 09/04/2007 | US7265226 Interact with opoid receptors; decreasing metabolic rates of the phenolic piperidines by amidation, imidation, or forming a formamide, a hydroxyamidine or a thioamide; analgesics, anticonvulsants, antitussive agents; diarrhea, drug addiction |
| 09/04/2007 | US7265221 Pyrrolo[2,3-d]pyrimidine compounds |
| 09/04/2007 | US7265220 Amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative |
| 09/04/2007 | US7265208 Autoimmune disease; allergies vaccine |
| 09/04/2007 | US7265154 Valproic acid and derivatives thereof as histone deacetylase inhibitors |
| 09/04/2007 | US7265146 Administering small molecule compounds, especially acids or esters, that inhibit the interaction between alpha 4 integrins and ligands MAdCAM and/or VCAM for treatment of chronic inflammatory diseases such as arthritis, asthma, multiple sclerosis, Chrohn's disease, ulcerative colitis, and hepatitis C |
| 09/04/2007 | US7265142 Materials and methods for the treatment of hypertension and angina |
| 09/04/2007 | US7265137 Phenylacetic acid derivative; hypoglycemic agents; antilipemic agents; anticholesterol agents; cardiovascular disorders |
| 09/04/2007 | US7265136 Substituted stilbene compounds with vascular damaging activity |
| 09/04/2007 | US7265135 Antihistamines; cognition activators; Alzheimer's disease; antiepileptic agents; eating disorders; motion sickness; psychological disorders |
| 09/04/2007 | US7265130 anti-obestic activity; Neuropeptide Y antagonist |
| 09/04/2007 | US7265125 4-Heteroaminoquinazoline derivatives,.e.g., 2-methyl-4-piperidin-1-yl-7-pyridin-3-yl-quinazoline; prophylaxis or treatment of arthritis, cardiovascular diseases, diabetes, renal failure and particularly eating disorders and obesity. |
| 09/04/2007 | US7265123 Heterocyclic compounds |
| 09/04/2007 | US7265119 For therapy of nicotine dependency |
| 09/04/2007 | US7265116 Attention deficit disorders; hyperactivity; post-trauma stress disorders; anxiolytic agents; obsessive compulsive disorders; analgesics; Parkinson's disease |
| 09/04/2007 | US7265113 Anticancer agents; antiinflammatory agents, for therapy of rheumatoid arthritis |
| 09/04/2007 | US7265110 Psychological disorders; antidepressants; anxiolytic agents; analgesics; antiinflammatory agents; central nervous system disorders |
| 09/04/2007 | US7265108 For example, 6-[2-[4-(2-fluorophenoxymethyl)piperidino]ethyl]-1H-pyrazin-2-one; therapeutic or prophylactic agent for diabetic neuralgia, HIV neuralgia, postherpetic neuralgia, nerve system disorders |
| 09/04/2007 | US7265104 Tetraazabenzo[e]azulene derivatives and analogs thereof |
| 09/04/2007 | US7265103 For therapy of depression, anxiety and body weight disorders |
| 09/04/2007 | US7265100 Separation of regioisomers of metal phthalocyanines |
| 09/04/2007 | US7265087 Exendin improves β-cell response in subjects with impaired glucose tolerance |
| 09/04/2007 | US7264953 Mutant proteinase-inhibitors and uses thereof |
| 09/04/2007 | US7264945 IFN receptor 1 binding proteins, DNA encoding them, and methods of modulating cellular response to interferons |
| 09/04/2007 | US7264935 Potassium-dependent sodium-calcium exchanger |
| 09/04/2007 | US7264928 whereby a DNA sample is tested for the presence of polymorphic allele; solid phase synthesis |
| 09/04/2007 | US7264814 wherein at least one non-essential gene for replication thereof is inactivated; side effect reduction |
| 09/04/2007 | US7264813 Therapeutic uses of Dunaliella powder |
| 09/04/2007 | US7264807 Administering to human therapeutically effective amount of antibody which binds to tropomyosin isoform associated with ulcerative colitis |
| 09/04/2007 | US7264799 Administering to patient before or simultaneously with surgery at least one heparinase enzyme, wherein heparinase enzyme decreases localized inflammatory response in the tissue of the patient |
| 09/04/2007 | US7264793 Numb protein expression inhibitors by Musashi |
| 09/04/2007 | CA2450789C Schwann cells originating in myeloid interstitial cells |
| 09/04/2007 | CA2444554C Pharmaceutical compositions of amlodipine and atorvastatin |
| 09/04/2007 | CA2297911C Substituted 6-phenylphenanthridines |
| 09/04/2007 | CA2258044C Muscarinic antagonists |
| 09/04/2007 | CA2219311C 10,13,15-trioxatricyclo[9.2.1.1.9.6]-pentadecanone derivatives, method for their production and pharmaceutical compositions containing them |
| 09/04/2007 | CA2215329C Colorectal chemoprotective composition and method for preventing colorectal cancer |
| 09/04/2007 | CA2134479C Laser treatment |
| 09/04/2007 | CA2116238C Oral 1 .alpha.-hydroxyprevitamin d |
| 08/30/2007 | WO2007097455A1 Novel compound isolated from plant 'pau-ferro' |
| 08/30/2007 | WO2007097403A1 Remedy or preventive for digestive ulcer |
| 08/30/2007 | WO2007097289A1 Novel pharmaceutical |
| 08/30/2007 | WO2007097276A1 Pyrrole derivative or salt thereof |
| 08/30/2007 | WO2007097197A1 Amide derivative or salt thereof |
| 08/30/2007 | WO2007096170A1 Use of sodium channel blockers for the treatment of preterm labor |
| 08/30/2007 | WO2007095688A1 Methods for increasing the number of circulating cells |
| 08/30/2007 | WO2007077365A3 IMMUNOGLOBULIN G (IgG) CONCENTRATE DEPLETED OF ANTI-A AND ANTI-B ANTIBODIES AND OF POLYREACTIVE IgGs |
| 08/30/2007 | US20070203357 Freeze-dried product of n-[o-(p-pivaloyloxy benzenesulfonylamino) benzoyl]glycine monosodium salt tetra-hydrate and a process for the manufacture thereof |
| 08/30/2007 | US20070203337 Use of 2-amino-thiazoline derivatives as inhibitors of inducible no-synthase |
| 08/30/2007 | US20070203223 Via amino ceramide-like compounds; lowering glycosphingolipid concentrations; Fabry's disease, Gaucher's disease |
| 08/30/2007 | US20070203211 Drug for preventing or treating angiogenic eye diseases |
| 08/30/2007 | US20070203198 Pioglitazone insulin sensitivity enhancer with the antidiabetic glimepiride; difference in mechanism of action avoids adverse reactions over long term use; oral dosage tablet; lactose excipient, hydroxypropylcellulose binder, magnesium stearate lubricant, calcium carbonate disintegrator; diabetes |
| 08/30/2007 | US20070203193 Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist |
| 08/30/2007 | US20070203189 having proinflammatory cytokine production inhibiting properties, in particular tumor necrosis factor-alpha (TNF-alpha) and/or interleukin-12 (IL-12) inhibiting properties, used for the prevention or the treatment of inflammatory and/or autoimmune diseases |
| 08/30/2007 | US20070203184 Novel Indolin-2-one Derivatives, Their Preparation and the Pharmaceutical Compositions Comprising Them |
| 08/30/2007 | US20070203141 Method for administering birb 796 bs |
| 08/30/2007 | US20070203138 Novel Compounds and Compositions as Cathepsin S Inhibitors |
| 08/30/2007 | US20070203090 N-pyrazole A2A receptor agonists |
| 08/30/2007 | US20070203068 Stimulation of beta cell proliferation |
| 08/30/2007 | US20070203063 Pharmaceutical compositions including variants of vascular endothelial cell growth factor having altererd pharmacological properties |
| 08/30/2007 | US20070203057 Compounds and methods for modulating adhesion molecule function |
| 08/30/2007 | US20070202516 Gene detection assay for improving the likelihood of an effective response to an egfr antagonist cancer therapy |
| 08/30/2007 | US20070202204 Plant extract mixtures and their uses |
| 08/30/2007 | US20070202198 Process of obtaining thylakoids from photosynthetic organisms; plant fractions obtained from the process; pure thylakoids; and methods of use of thylakoids as ROS scavengers, photo-protectors, biosensors biofilters and bioreactors |
| 08/30/2007 | US20070202196 Plant extract mixtures and their uses |
| 08/30/2007 | US20070202160 Solid-state form of celecoxib having enhanced bioavailability |
| 08/30/2007 | US20070202134 Muc1 Antagonist Enhancement of Death Receptor Ligand-Induced Apoptosis |
| 08/30/2007 | US20070202133 BENZIMIDAZOLE COMPOUNDS FOR MODULATING IgE AND INHIBITING CELLULAR PROLIFERATION |
| 08/30/2007 | US20070202115 Preparation for the prevention and/or treatment of a tissue change of mesenchymal origin |
| 08/30/2007 | US20070202101 Combination therapy using anti-EGFR antibodies and anti-hormonal agents |
| 08/30/2007 | US20070202083 Carbon monoxide improves outcomes in tissue and organ transplants and suppresses apoptosis |
| 08/30/2007 | CA2643272A1 Gent for treating or preventing digestive ulcer |
| 08/30/2007 | CA2642619A1 Pyrrole derivative or salt thereof |